NeuroPace Statistics
Want to see NPCE full AI Analyst Report?
NeuroPace (NPCE) Stock Statistics & Valuation Metrics
Total Valuation
NeuroPace has a market cap or net worth of $282.50M. The enterprise value is $492.92M.
- Market Cap
- $282.50M
- Enterprise Value
- $492.92M
Share Statistics
NeuroPace has 34,451,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 34,451,570
- Owned by Insiders
- 16.63%
- Owned by Institutions
- 75.05%
Financial Efficiency
NeuroPace’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -18.18%.
- Return on Equity (ROE)
- -1.13
- Return on Assets (ROA)
- -0.20
- Return on Invested Capital (ROIC)
- -18.18%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 462.90K
- Profits Per Employee
- -99.38K
- Employee Count
- 216
- Asset Turnover
- 0.95
- Inventory Turnover
- 1.35
Valuation Ratios
The current PE Ratio of NeuroPace is -14.63. NeuroPace’s PEG ratio is -0.47.
- PE Ratio
- -14.63
- PS Ratio
- 2.99
- PB Ratio
- 24.57
- Price to FCF
- -22.81
- Price to Operating Cash Flow
- -23.41
- PEG Ratio
- -0.47
Income Statement
In the last 12 months, NeuroPace had revenue of 99.99M and earned -21.46M in profits. Earnings per share was -0.66.
- Revenue
- 99.99M
- Gross Profit
- 77.22M
- Operating Income
- -16.34M
- Pretax Income
- -21.46M
- Net Income
- -21.46M
- EBITDA
- -12.06M
- Earnings Per Share (EPS)
- -0.66
Cash Flow
In the last 12 months, operating cash flow was -12.06M and capital expenditures -355,000, giving a free cash flow of -12.41M billion.
- Operating Cash Flow
- -12.06M
- Free Cash Flow
- -12.41M
- Free Cash Flow per Share
- -0.36
Dividends & Yields
NeuroPace pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.38%
- Earnings Yield
- -6.70%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -36.87%
- 50-Day Moving Average
- 13.07
- 200-Day Moving Average
- 14.71
- Relative Strength Index (RSI)
- 26.46
- Average Volume (3m)
- 254.94K
Important Dates
NeuroPace upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Mar 09, 2027
- Ex-Dividend Date
- ―
Financial Position
NeuroPace as a current ratio of 5.28, with Debt / Equity ratio of 372.22%
- Current Ratio
- 5.28
- Quick Ratio
- 4.33
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- -4.08
- Interest Coverage Ratio
- -2.19
Taxes
In the past 12 months, NeuroPace has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
NeuroPace EV to EBITDA ratio is -31.01, with an EV/FCF ratio of -27.59.
- EV to Sales
- 3.62
- EV to EBITDA
- -31.01
- EV to Free Cash Flow
- -27.59
- EV to Operating Cash Flow
- -28.40
Balance Sheet
NeuroPace has $49.23M in cash and marketable securities with $69.54M in debt, giving a net cash position of -$20.31M billion.
- Cash & Marketable Securities
- $49.23M
- Total Debt
- $69.54M
- Net Cash
- -$20.31M
- Net Cash Per Share
- -$0.59
- Tangible Book Value Per Share
- $0.33
Margins
Gross margin is 81.41%, with operating margin of -15.39%, and net profit margin of -20.00%.
- Gross Margin
- 81.41%
- Operating Margin
- -15.39%
- Pretax Margin
- -20.00%
- Net Profit Margin
- -20.00%
- EBITDA Margin
- -11.68%
- EBIT Margin
- -13.42%
Analyst Forecast
The average price target for NeuroPace is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $11.00
- Price Target Upside
- 33.82% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 8
- Revenue Growth Forecast
- -0.29%
- EPS Growth Forecast
- 25.96%
Scores
- Smart Score
- 4
- AI Score
- 40

